Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Thouvenot

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Journal of Neurology|April 2, 2024
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sexNaila Makhani, Christine Lebrun-Frenay, Aksel Siva, et al.
JAMA Neurology|March 23, 2026
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseMarine Boudot de la Motte, Antoine Gavoille, Caroline Papeix, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Neurology|June 20, 2024
Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative StudyLou Grangeon, Grégoire Boulouis, Jean Capron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2021
Determinants of therapeutic lag in multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2021
High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 familiesMehdi Benkirane, Cecilia Marelli, Claire Guissart, et al.
CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
JAMA Neurology|March 25, 2024
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MSGuillaume Jouvenot, Guilhem Courbon, Mathilde Lefort, et al.
Journal of Neurology|April 2, 2024
The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sexNaila Makhani, Christine Lebrun-Frenay, Aksel Siva, et al.
JAMA Neurology|March 23, 2026
Treatment Discontinuation in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseMarine Boudot de la Motte, Antoine Gavoille, Caroline Papeix, et al.
Neurology|May 5, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple SclerosisAntoine Gavoille, Anne Kerbrat, Gilles Edan, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patientsDaniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
Neurology|June 20, 2024
Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative StudyLou Grangeon, Grégoire Boulouis, Jean Capron, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 11, 2021
Determinants of therapeutic lag in multiple sclerosisIzanne Roos, Emmanuelle Leray, Federico Frascoli, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 8, 2021
High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 familiesMehdi Benkirane, Cecilia Marelli, Claire Guissart, et al.
CNS Drugs|April 4, 2026
Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort StudyIzanne Roos, Sifat Sharmin, Serkan Ozakbas, et al.
Pageof 15